Improperly designed, manufactured, or labeled drugs and medical devices can cause serious injuries or death. Prescription medications may be improperly marketed or prescribed.
Why are prescription drug recalls so frequently discussed in the media? Prescription drugs are often rushed to market without adequate testing. Of all the recent examples of harmful drugs, most were withdrawn from sale within 12 months of release. In some cases, there is evidence that manufacturers had knowledge of the serious side effects caused by their drugs. The long-term effects of prescription medications are difficult to determine.
Contact our lawyers today if you, or a loved one, have suffered serious side effects, including heart attack, stroke, blood clots, or other injuries, that you believe were caused by a prescription drug. You may be eligible for compensation.
-----------------------------------------------------
Crestor
Controversy abounds regarding the cholesterol
lowering “statin” drugs, including Crestor, (rosuvastatin)
which was approved by the Food & Drug Administration
(FDA) in August of 2003. Crestor side effects may
include risk of muscle and kidney damage.
-----------------------------------------------------
Fosamax recently has been linked to osteonecrosis of the jaw (ONJ), a rare and serious condition that causes the jaw bone to partially crumble and die. ONJ is also known as “bone death of the jaw.” The majority of the reported cases are in cancer patients who are having, or have had, a dental procedure.
-----------------------------------------------------
Ketek is a prescription antibiotic used to kill
bacteria that cause sinus and other respiratory
infections, including chronic bronchitis and
pneumonia, but studies have linked it to serious liver injury, liver failure and death.
-----------------------------------------------------
Vioxx is a
member of the
non-steroidal anti-inflammatory drugs (NSAID)
family of pain medications used to treat the severe
pain associated with osteoarthritis, rheumatoid
arthritis, and acute menstrual cramping. Merck & Co.
pulled Vioxx (rofecoxib)
from the market in September of 2004 after a
study found that the drug doubled the risk of heart
attack.
-----------------------------------------------------
Zyprexa (Olanzapine)
was approved by the Food and Drug Administration
(FDA) in 1996 for the treatment of schizophrenia and
acute bipolar mania. In March of 2004, the FDA and
Eli Lilly and Company informed healthcare
professionals that the Zyprexa label warnings would
include the description of increased risk of
hyperglycemia and diabetes in patients who take
Zyprexa.
-----------------------------------------------------